Higher Tinzaparin Dosing Is Needed to Achieve Target Anti-Xa Levels in Pediatric Cardiac Intensive Care Patients

Author(s):
Roeleveld, P.P. (0000-0001-5491-9408); Hoeven, A. van der (0000-0002-4189-9564); Wilde, R.B.P. de; Eikenboom, J.; Smiers, F.J.; Bunker-Wiersma, H.E.
Published
2016
Publication type
Article / Letter to editor
anti-Xachildpediatric intensive carepharmacokineticslow-molecular weight heparintinzaparin
Date issued
2016-03-31
Language
English
Is part of
Pediatric Critical Care Medicine (2016), Vol. 17, no. 3, p. 203-209
hdl
1887/112056
doi
10.1097/PCC.0000000000000640